Yes thats ironic. If Anavex sells the voucher then they do no longer believe in a short term approval of any of their trials. If they believe one of their trials between now and 6-9 months needs to be reviewed for marketing purposes then they will keep the voucher themself untill that date somewhere in 2020. The voucher offers a quick review and must be announced 90 days prior to the review. Well if Anavex does not believe in a request for review in 2020 for any of the trials then why not sell the voucher for $ 350 million today..?
News 
Market Data 
Discover 
